Effects of Follicle-stimulating Hormone on Fat Metabolism and Cognitive Impairment in Women During Menopause
Overview
Authors
Affiliations
Lipid metabolism disorder is a common pathological manifestation of menopausal women, and is also an important risk factor for many diseases at this stage of life. Epidemiological studies have shown that high levels of follicle-stimulating hormone (FSH) in menopausal women are closely associated with changes in body composition, central obesity, and cognitive decline. Exogenous FSH causes growth and proliferation of adipose, whereas blockage of the FSH signaling pathway leads to decline in adipose. Mechanistically, FSH, FSH receptor (FSHR), G protein coupling, gene mutation and other pathways are involved in adipogenesis and cognitive impairment. Here, we review the critical role and potential interactions of FSH in adipogenesis and cognitive impairment in menopausal women. Further understanding of the exact mechanisms of FSH aggravating obesity and cognitive impairment may provide a new perspective for promoting healthy aging in menopausal women.
Female reproductive health trends and autism spectrum disorder prevalence between 2000 and 2024.
Al-Salihy A Sci Rep. 2025; 15(1):8507.
PMID: 40075145 PMC: 11904183. DOI: 10.1038/s41598-025-89979-x.
Estropausal gut microbiota transplant improves measures of ovarian function in adult mice.
Kim M, Wang J, Pilley S, Lu R, Xu A, Kim Y bioRxiv. 2025; .
PMID: 40060387 PMC: 11888174. DOI: 10.1101/2024.05.03.592475.
Gilmer G, Iijima H, Hettinger Z, Jackson N, Bergmann J, Bean A Nat Aging. 2025; 5(1):65-86.
PMID: 39820791 DOI: 10.1038/s43587-024-00773-2.
Guedes J, Pla I, Sanchez A, Marko-Varga G, Domont G, Sahlin K Endocr Connect. 2025; 14(2).
PMID: 39745472 PMC: 11770401. DOI: 10.1530/EC-24-0587.
Xiao H, Li W, Qin Y, Lin Z, Qian C, Wu M Research (Wash D C). 2024; 7:0447.
PMID: 39165638 PMC: 11334918. DOI: 10.34133/research.0447.